SCHEMBL30962948

SCHEMBL30962948

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C)c2)nc(-c2c(F)ccc(F)c2Cl)c1C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 2/20 0.40
▸ WEE1 P30291 1/20 0.40
▸ EHMT2 Q96KQ7 1/20 0.40
▸ JAK2 O60674 4/20 0.38
▸ PIK3CD O00329 3/20 0.37
▸ CSF1R P07333 3/20 0.37
▸ CDK4 P11802 3/20 0.37
▸ CDK6 Q00534 3/20 0.37
▸ MAP4K1 Q92918 1/20 0.36
▸ TBK1 Q9UHD2 3/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ AXL P30530 2/20 0.36
▸ EGFR P00533 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ BCL6 P41182 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962810 0.92 WEE1 (0.44) ALKWEE1EHMT2JAK2PIK3CD
SCHEMBL30962824 0.90 WEE1 (0.42) ALKWEE1EHMT2JAK2PIK3CD
SCHEMBL30962936 0.89 WEE1 (0.41) ALKWEE1EHMT2JAK2PIK3CD
SCHEMBL30962797 0.89 WEE1 (0.47) ALKWEE1EHMT2JAK2CDK4
SCHEMBL30962784 0.89 ALK (0.41) ALKWEE1EHMT2JAK2PIK3CD
SCHEMBL30962777 0.88 WEE1 (0.46) ALKWEE1EHMT2JAK2CDK4
SCHEMBL30962668 0.87 WEE1 (0.41) ALKWEE1EHMT2JAK2TBK1
SCHEMBL30962727 0.86 ALK (0.45) ALKWEE1EHMT2CDK4CDK6
SCHEMBL30962572 0.85 WEE1 (0.41) ALKWEE1EHMT2JAK2TBK1
SCHEMBL30962694 0.85 WEE1 (0.44) ALKWEE1EHMT2JAK2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback